225 related articles for article (PubMed ID: 19074878)
1. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
2. The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
Tesfaye A; Di Cello F; Hillion J; Ronnett BM; Elbahloul O; Ashfaq R; Dhara S; Prochownik E; Tworkoski K; Reeves R; Roden R; Ellenson LH; Huso DL; Resar LM
Cancer Res; 2007 May; 67(9):3998-4004. PubMed ID: 17483309
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
[TBL] [Abstract][Full Text] [Related]
4. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
5. STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.
Belton A; Xian L; Huso T; Koo M; Luo LZ; Turkson J; Page BD; Gunning PT; Liu G; Huso DL; Resar LM
Leuk Lymphoma; 2016 Nov; 57(11):2681-4. PubMed ID: 26952843
[No Abstract] [Full Text] [Related]
6. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
7. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway.
Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R
Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 down-regulation is crucial for chromatin composition and a gene expression profile permitting myogenic differentiation.
Brocher J; Vogel B; Hock R
BMC Cell Biol; 2010 Aug; 11():64. PubMed ID: 20701767
[TBL] [Abstract][Full Text] [Related]
10. The high mobility group A1 gene: transforming inflammatory signals into cancer?
Resar LM
Cancer Res; 2010 Jan; 70(2):436-9. PubMed ID: 20068164
[TBL] [Abstract][Full Text] [Related]
11. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
[TBL] [Abstract][Full Text] [Related]
12. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
13. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
14. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
15. Hmga1 is differentially expressed and mediates silencing of the CD4/CD8 loci in T cell lineages and leukemic cells.
Xi Y; Watanabe S; Hino Y; Sakamoto C; Nakatsu Y; Okada S; Nakao M
Cancer Sci; 2012 Mar; 103(3):439-47. PubMed ID: 22106824
[TBL] [Abstract][Full Text] [Related]
16. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.
Di Cello F; Dhara S; Hristov AC; Kowalski J; Elbahloul O; Hillion J; Roy S; Meijerink JP; Winter SS; Larson RS; Huso DL; Resar L
Leuk Lymphoma; 2013 Aug; 54(8):1762-8. PubMed ID: 23311322
[TBL] [Abstract][Full Text] [Related]
18. High mobility group A1 and cancer: potential biomarker and therapeutic target.
Shah SN; Resar LM
Histol Histopathol; 2012 May; 27(5):567-79. PubMed ID: 22419021
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GACAT3 acts as a competing endogenous RNA of HMGA1 and alleviates cucurbitacin B-induced apoptosis of gastric cancer cells.
Lin Y; Li J; Ye S; Chen J; Zhang Y; Wang L; Xi Y; Bu S; Qiu X
Gene; 2018 Dec; 678():164-171. PubMed ID: 30098426
[TBL] [Abstract][Full Text] [Related]
20. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
